Capricor Therapeutics short interest was 42.13% of the float on August 31st, according to new data we received from Benzinga. Short interest totaled 22,183,275 shares, which was an increase of 24.94% from August 14th.
It is estimated that it would take 1.99 days for short sellers to buy back their shares, with current trading volumes.
Capricor Therapeutics Hedge Fund Activity
We have seen 99 institutional investors add shares of Capricor Therapeutics stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC added 2,399,900 shares (+141.2%) to their portfolio in Q2 2026, for an estimated $57,789,591
- SUVRETTA CAPITAL MANAGEMENT, LLC added 2,032,990 shares (+113.9%) to their portfolio in Q1 2026, for an estimated $61,802,896
- STATE STREET CORP added 1,215,249 shares (+55.7%) to their portfolio in Q2 2026, for an estimated $29,263,195
- BOXER CAPITAL MANAGEMENT, LLC added 805,156 shares (+136.5%) to their portfolio in Q2 2026, for an estimated $19,388,156
- DARWIN GLOBAL MANAGEMENT, LTD. removed 800,000 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $24,320,000
- SOLEUS CAPITAL MANAGEMENT, L.P. added 761,737 shares (+inf%) to their portfolio in Q2 2026, for an estimated $18,342,626
- POINT72 ASSET MANAGEMENT, L.P. removed 726,456 shares (-88.5%) from their portfolio in Q2 2026, for an estimated $17,493,060
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Capricor Therapeutics Insider Trading Activity
Capricor Therapeutics insiders have traded $CAPR stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $CAPR stock by insiders over the last 6 months:
- KARIMAH ES SABAR has made 0 purchases and 3 sales selling 122,529 shares for an estimated $3,756,395.
- ANTHONY BERGMANN (CHIEF FINANCIAL OFFICER) has made 0 purchases and 5 sales selling 75,000 shares for an estimated $2,304,850.
- KAREN KRASNEY (EVP, GENERAL COUNSEL) has made 0 purchases and 5 sales selling 75,000 shares for an estimated $2,304,640.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
